Objective: To evaluate the short-term effectiveness of an intensive multidisciplinary rehabilitation programme for people with Parkinson's disease and their carers.
Design: Observational, with assessments before and after intervention.
Setting: An elderly care day unit in a district general hospital in south-east England.
Subjects: One hundred and eighteen people with Parkinson's disease and no cognitive impairment, and their carers.
Intervention: Participants attended the day hospital in groups of six patients with their carers for one day per week over six consecutive weeks. After assessment, they received individual treatment from a specialist team. Weekly group activities included relaxation and talks from experts.
Outcome measures: Patients and carers were assessed for: health-related quality of life, psychological well-being, social services need, perceptions of the programme. Patients were additionally assessed for mobility, gait and speech. Carers were assessed for strain.
Results: After treatment significant improvements were recorded in patients' mobility and gait (p < 0.05), speech (p < 0.001), depression (p = 0.029), health-related quality of life (p = 0.001). People with more advanced disease at baseline gained significantly more from treatment (p £ 0.04). Carers were less depressed and had higher health-related quality of life than patients at baseline (p < 0.001) and no improvements in these indicators were recorded after treatment. A high unmet need for social services was identified in 31% of participants, and 10% of carers were found in danger of being unable to continue caring. Participants reported knowledge gains and high levels of satisfaction with both individual therapies and group activities.
Conclusions: This intensive co-ordinated programme provided immediate benefits to people with Parkinson's disease and their carers.
Get full access to this article
View all access options for this article.
References
1.
Gage H. The effectiveness of rehabilitation in Parkinson's disease: A review of available evidence. Mimeo, available from the authors.
2.
McCall B. Coping with Parkinson's disease: the patients' and carers' experience. Br J Ther Rehabil1995; 2: 549–554.
3.
MacMahon D. Parkinson's disease. Geriatr Med1996; 26: 35–36, 59–62, 42–45.
4.
Carlson-Davis J. Team management of Parkinson's disease. Am J Occup Ther1977; 31: 300–308.
5.
Cutson T, Cotter Laub K, Schenkman M. Pharmacological and nonpharmacological interventions in the treatment of Parkinson's disease. Phys Ther1995; 75: 363–373.
6.
Feldman R. Parkinson disease. Individualising therapy. Hosp Pract1985; 80A–80FF:
7.
Lannon M, Thomas C-A, Bratton M, Jost M, Lockhart-Pretti P. Comprehensive care of the patient with Parkinson's disease. J Neurosc Nurs1986; 18: 122–131.
8.
Lieberman A. An integrated approach to patient management in Parkinson's disease. Neurol Clin1992; 10: 553–565.
9.
Risdale L. Community care for patients with idiopathic Parkinson's disease. Br J Gen Pract1995; 226–227.
10.
Schankman M, Butler R. A model for multisystem evaluation treatment of individuals with Parkinson's disease. Phys Ther1989; 69: 932–943.
11.
Kaye J. A rehabilitation programme for people with Parkinson's Disease. Elderly Care1999; 11: 34–36.
12.
Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing1972; 233–238.
13.
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology1967; 17: 427–442.
14.
Wade DT, Collin C. The Barthel ADL index: a standard measure of physical disability?Int Disabil Stud1988; 10: 64–67.
15.
Zigmond AS, Snouth RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand1983; 67: 361–370.
16.
Kind P. The EuroQol instrument: an index of health-related quality of life. In: Spiker B ed. Quality of life and pharmacoeconomics in clinical trials, second edition. Philidelphia: Lippincott-Raven, 1996: 191–201.
17.
Emerson J, Enderby P. Prevalence of speech and language disorders in a mental illness unit. Eur J Disord Commun1996; 31: 221–226.
Schulz G, Grant M. Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson's disease: a review of the literature. J Commun Disord2000; 33: 59–88.
20.
Lloyd M. The new community care for people with Parkinson's disease and their carers. In: Percival R, Hobson P eds. Parkinson's disease: studies in psychological and social care. The British Psychological Society and The Parkinson's Disease Society, 1999: chapter 2.
21.
Jones R, D'eath C, Harnsford J, Hutchinson H, Hyde L, Thurlow L, Spanton L. The needs of people with Parkinson's disease and their families: The Parkinson's disease study, Devon and Cornwall 1989–92. In: Percival R, Hobson P eds. Parkinson's disease: studies in psychological and social care. The British Psychological Society and The Parkinson's Disease Society, 1999: chapter 3.
22.
Clarke CE, Zobkiw RM, Gullaksen E. Quality of life and care in Parkinson's disease. Br J Clin Pract1995; 49: 288–293.
23.
Mutch W, Strudwick A, Roy S, Downie A. Parkinson's disease: disability, review and management. BMJ1986; 293: 675–677.
24.
Peto V, Fitzpatrick R, Jenkinson C. Self-reported health status and access to health services in a community sample with Parkinson's disease. Disabil Rehabil1997; 19: 19–103.
25.
Yarrow S. Members' 1998 survey of the Parkinson's Disease Society in the UK. In: Percival R, Hobson P eds. Parkinson's disease: studies in psychological and social care. The British Psychological Society and The Parkinson's Disease Society, 1999: chapter 4.
26.
Ward C. Rehabilitation in Parkinson's disease. Rev Clin Gerontol1992; 2: 254–268.
27.
Greenwood R. The future of rehabilitation. BMJ2001; 323: 1082–1083.
